Pacific Biosciences Of California (PACB) Operating Income (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Operating Income of -$8.4 million for Q1 2026, up 98.05% year-over-year from -$4.2 million in Q1 2025, and up 79.71% quarter-over-quarter from -$41.2 million in Q4 2025.
Pacific Biosciences Of California (PACB) Operating Income (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Operating Income history runs 17 years deep, the most recent figure standing at -$8.4 million for Q1 2026.
- In Q1 2026, Operating Income rose 98.05% year-over-year to -$8.4 million; the TTM figure through Mar 2026 stood at -$133.3 million (up 83.78% YoY), while the FY2025 annual figure was -$553.9 million, down 16.77% from the prior year.
- Operating Income for Q1 2026 stood at -$8.4 million, up from -$41.2 million in the prior quarter.
- The five-year high for Operating Income was -$8.4 million in Q1 2026, with the low at -$428.9 million in Q1 2025.
- The 5-year median for Operating Income is -$77.5 million (2022), against an average of -$98.7 million.
- The sharpest annual moves came in 2025 and 2026: Operating Income tumbled 427.19% in 2025, then soared 98.05% in 2026.
- Pacific Biosciences Of California's Operating Income stood at -$87.1 million in 2022, then slipped by 0.53% to -$87.5 million in 2023, then slumped by 74.79% to -$153.0 million in 2024, then jumped by 73.08% to -$41.2 million in 2025, then jumped by 79.71% to -$8.4 million in 2026.
- Business Quant data shows PACB's Operating Income at -$8.4 million in Q1 2026, -$41.2 million in Q4 2025, and -$38.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | -44.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.61 Mn |
| Mar 31, 2026 | -8.36 Mn |
| Dec 31, 2025 | -41.20 Mn |
| Sep 30, 2025 | -38.88 Mn |
| Jun 30, 2025 | -44.85 Mn |
| Mar 31, 2025 | -428.93 Mn |
| Dec 31, 2024 | -153.03 Mn |
| Sep 30, 2024 | -64.08 Mn |
| Jun 30, 2024 | -175.85 Mn |
| Mar 31, 2024 | -81.36 Mn |
| Dec 31, 2023 | -87.55 Mn |
| Sep 30, 2023 | -82.49 Mn |
| Jun 30, 2023 | -73.18 Mn |
| Mar 31, 2023 | -91.25 Mn |
| Dec 31, 2022 | -87.08 Mn |
| Sep 30, 2022 | -74.62 Mn |
| Jun 30, 2022 | -67.97 Mn |
| Mar 31, 2022 | -77.52 Mn |
| Dec 31, 2021 | -64.68 Mn |
| Jun 30, 2021 | -37.57 Mn |